Scholarly Index
Chao Li
Eli Lilly (United States); 3,502 total citations; 148 total publications; best world rank #15
Eli Lilly (United States)
3,502Total citations
148Total publications
33H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 918 | US 374 | 96.05 |
| Occupational and environmental lung diseases | Lifetime | 699 | US 272 | 93.87 |
| Occupational and environmental lung diseases | 2021-2025 | 15 | US 3 | 97.59 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 90 | US 27 | 98.08 |
| Immune cells in cancer | 2021-2025 | 896 | US 190 | 88.45 |
| Occupational exposure and asthma | 2021-2025 | 355 | US 60 | 69.58 |